We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$729M
AUM Growth
+$226M
Cap. Flow
+$172M
Cap. Flow %
23.64%
Top 10 Hldgs %
50.98%
Holding
608
New
234
Increased
78
Reduced
67
Closed
221

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$32.8M
2
BAC icon
Bank of America
BAC
+$10.9M
3
AMZN icon
Amazon
AMZN
+$8.85M
4
VOYA icon
Voya Financial
VOYA
+$8.52M
5
CFG icon
Citizens Financial Group
CFG
+$7.49M

Sector Composition

Rank Sector Weight
1 Financials 12.9%
2 Technology 12.09%
3 Consumer Discretionary 11.37%
4 Healthcare 5.03%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVA icon
101
Innoviva
INVA
$1.48B
$885K 0.12%
+62,508
New +$767K
RUN icon
102
Sunrun
RUN
$2.46B
$876K 0.12%
+63,416
New +$946K
EBAY icon
103
eBay
EBAY
$49.8B
$873K 0.12%
24,175
+15,175
+169% +$550K
CXP
104
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$856K 0.12%
40,931
+21,046
+106% +$432K
PDLI
105
DELISTED
PDL BioPharma, Inc.
PDLI
$852K 0.12%
262,508
+186,488
+245% +$541K
STX icon
106
Seagate
STX
$184B
$840K 0.12%
+14,111
New +$811K
AZPN
107
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$831K 0.11%
6,869
+3,784
+123% +$458K
VIPS icon
108
Vipshop
VIPS
$7.53B
$828K 0.11%
58,436
+42,745
+272% +$506K
KLAC icon
109
KLA
KLAC
$259B
$816K 0.11%
45,800
+6,580
+17% +$110K
BLDR icon
110
Builders FirstSource
BLDR
$8.04B
$814K 0.11%
+32,033
New +$765K
DHI icon
111
D.R. Horton
DHI
$42.3B
$814K 0.11%
15,435
+7,697
+99% +$411K
BR icon
112
Broadridge
BR
$19B
$804K 0.11%
+6,510
New +$796K
IBM icon
113
IBM
IBM
$224B
$804K 0.11%
+6,277
New +$816K
UPBD icon
114
Upbound Group
UPBD
$1.16B
$792K 0.11%
27,742
+13,542
+95% +$354K
NAVI icon
115
Navient
NAVI
$853M
$779K 0.11%
+56,935
New +$766K
CIT
116
DELISTED
CIT Group Inc.
CIT
$750K 0.1%
16,444
-1,511
-8% -$67.7K
IRWD icon
117
Ironwood Pharmaceuticals
IRWD
$714M
$745K 0.1%
+55,944
New +$617K
SLRC icon
118
SLR Investment Corp
SLRC
$715M
$744K 0.1%
+36,062
New +$741K
JAZZ icon
119
Jazz Pharmaceuticals
JAZZ
$16.7B
$738K 0.1%
4,941
+1,667
+51% +$227K
AFL icon
120
Aflac
AFL
$62.6B
$734K 0.1%
+13,867
New +$736K
CCEP icon
121
Coca-Cola Europacific Partners
CCEP
$47.9B
$731K 0.1%
+14,360
New +$756K
ESNT icon
122
Essent Group
ESNT
$6.33B
$722K 0.1%
13,884
-844
-6% -$44K
SPNS
123
DELISTED
Sapiens International
SPNS
$716K 0.1%
31,133
-10,694
-26% -$231K
HPE icon
124
Hewlett Packard
HPE
$70.5B
$703K 0.1%
44,313
+22,538
+104% +$360K
CMBT
125
CMB.TECH NV
CMBT
$4.73B
$702K 0.1%
+55,944
New +$619K

Similar funds

Caxton Associates (New York)'s Q4 2019 Portfolio in Review

As of Q4 2019, Caxton Associates (New York) held 608 positions worth $729M, up 45% from $503M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Caxton Associates (New York) deployed $172M of net new capital in Q4 2019, opening 234 new positions and adding to 78 existing holdings. Its largest new stake was Aptiv: 358,663 shares worth $34.1M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 9.2% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $53.8M trimmed.

  • Caxton Associates (New York)'s largest Q4 2019 buy was Aptiv: 358,663 shares worth $34.1M.
  • Caxton Associates (New York) added most to Bank of America in Q4 2019, an estimated $10.9M increase.
  • Caxton Associates (New York)'s biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $53.8M.
  • Caxton Associates (New York) fully exited Cheniere Energy in Q4 2019, selling an estimated $36.5M.
  • Caxton Associates (New York)'s ten largest holdings make up 51% of its $729M portfolio in Q4 2019.
  • Caxton Associates (New York) opened 234 new positions and closed 221 in Q4 2019.
  • Caxton Associates (New York)'s portfolio value rose 45% quarter-over-quarter to $729M.

Based on Caxton Associates (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.